Oncoheroes Biosciences And Fundación Olivares: It Is Time For New And Better Therapies

by Oncoheroes Biosciences

Pediatric oncologists are forced to adjust adult cancer treatments for childhood cancer due to insufficient specific therapies for children with cancer.

Read more

Oncoheroes Biosciences And The Scott Carter Foundation Are Onboard To End Childhood Cancer

by Oncoheroes Biosciences

Childhood cancer is considered a rare disease that accounts for about 1% of all U.S. cancer diagnoses. Because of improved tumor detection and treatment advances in recent decades, 84% of children wit...

Read more

Oncoheroes Biosciences And Swifty Foundation United Toward New Cures

by Oncoheroes Biosciences

Childhood cancer is considered a rare disease that accounts for about 1% of all U.S cancers.

Read more

Oncoheroes Biosciences And Kier’s Kidz Helping Kids Beat Cancer Together

by Oncoheroes Biosciences

​Every day, more than 800 children are diagnosed with cancer worldwide.

Read more

MEET A HERO: Grant, 2 year old at diagnosis

by Oncoheroes Biosciences

"Upside down," said Grant looking at himself in the mirror and pointing at his Spiderman T-shirt while standing up on a hospital bed. Grant Gossling was 2 years old when he was diagnosed with high-ris...

Read more

SHEPHERD Therapeutics and Oncoheroes Biosciences to Partner for the Discovery, Development and Commercialization of Oncology Therapeutics For Rare Cancers

by Oncoheroes Biosciences

SHEPHERD Therapeutics, a company dedicated to catalyzing lifesaving treatments for rare cancer patients, and Oncoheroes Biosciences, a biotech company focused on advancing new therapies for childhood ...

Read more

The Gregory Foundation For Cancer Research Strengthens Their Commitment By Investing Again In Oncoheroes Biosciences

by Oncoheroes Biosciences

“Although Gregory received cutting edge immunotherapies and targeted therapies, including CAR-T 19 and an allogeneic CAR-T, the disease was very aggressive, and he succumbed to cancer,” explained ...

Read more

Catalytic Impact Foundation Invests in Oncoheroes Biosciences Endorsing Its Unique Effort To Treat Childhood Cancers

by Oncoheroes Biosciences

Childhood cancer is considered a rare disease that accounts for about 1% of all U.S. cancer diagnoses. Although pediatric cancer death rates have declined over the past four decades due to improved tu...

Read more

Oncoheroes Joins the Coalition Against Childhood Cancer (CAC2)

by Oncoheroes Biosciences

Oncoheroes today announced its organizational membership into the Coalition Against Childhood Cancer, known as CAC2, a collaborative network of organizations and individuals supporting and servicing t...

Read more

Volasertib, a potential new treatment for rhabdomyosarcoma, receives Orphan Drug Designation from the U.S. FDA

by Oncoheroes Biosciences

Oncoheroe​s Biosciences, a biotech focused on advancing new therapies for childhood cancer, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation (ODD) to vo...

Read more

Talk to Ricardo Garcia at BIO Investor Forum Digital, Oct 13-15

by Oncoheroes Biosciences

As many other events this year, Bio Investors Forum (Oct 13-15) is going remote. This is a unique opportunity where international biotech investor meet with early and established private companies as ...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New findings for a better understanding ...

by Universitat de Barcelona

A study published in Pediatric Neurology provides a better understandi...

Photos Stream